What’s new in nano
Every dated step in the nanotechnology we track, newest first. Each one says what happened, why it matters and how far it is from your life, with its source. New ones arrive every morning.
1 step
Oct 2026
- mRNA cancer vaccine
Full results from 1,137 patients, presented at the ESMO Congress in Madrid: adding the vaccine to Keytruda cut the risk of recurrence or death by 42%.
Real-world testing
1 step
Sept 2026
- NBTXR3
Nanobiotix reported that the FDA had cleared changes to the Johnson & Johnson-led phase 3 trial in head and neck cancer, NANORAY-312, so that its final analysis can come sooner.
Approved or on sale
1 step
Aug 2026
- mRNA cancer vaccine
Merck and Moderna said their phase 3 trial in people whose high-risk melanoma had been removed met its main goal: with Keytruda, the vaccine lowered the risk of the cancer returning.
Real-world testing
1 step
July 2026
- Tandem solar
A LONGi tandem cell reached 35.5% efficiency, a world record, certified by the European Solar Test Installation.
Approved or on sale
1 step
June 2026
- Nanotube additives
Batteries containing OCSiAl's nanotubes were powering about a million electric vehicles, and Volkswagen's battery company PowerCo picked OCSiAl as a supplier for its Unified Cell.
Everyday life
2 steps
Jan 2026
- Nanosheet transistors
Intel launched Core Ultra Series 3, its first chips made on its 18A process with its new RibbonFET transistors. Pre-orders for laptops opened on January 6, 2026, with more than 200 designs expected.
Approved or on sale - In-body gene editing
The FDA lifted the hold on MAGNITUDE-2, the trial in the nerve form of the disease, with closer monitoring of liver tests. The hold on the heart trial, MAGNITUDE, stayed.
Real-world testing